期刊文献+

原发性醛固酮增多症的分型、定侧诊断 被引量:2

Diagnosis of subtypes and lateralization for primary hyperaldosteronism
下载PDF
导出
摘要 目的 :探讨CT及体位刺激试验对原发性醛固酮增多症 (原醛 )分型、定侧诊断的价值。方法 :采用回顾性研究方法 ,对 2 2例原醛患者的临床资料及病理结果进行统计分析。结果 :醛固酮腺瘤 (APA)患者基础血浆醛固酮水平 (PAC)多 >2 5 0pg·ml-1。CT检查诊断APA的灵敏度为 75 % ,特异度 10 0 % ;体位刺激试验分别为 87%和 10 0 %。两方法诊断结果无显著相关性 (P >0 .0 5 ) ,两者结果一致性较差 (P >0 .0 5 ) ,但两者诊断效能差异无显著性 (P >0 .0 5 )。结论 :临床诊断APA以基础PAC及体位刺激试验为最佳。CT和体位刺激试验对APA均具较好的诊断价值 。 Objective To evaluate the value of CT and posture stimulation test (PST) in the differential diagnosis and lateralization of primary hyperaldosteronism(PA). Method Retrospective study was done based on the clinical data and pathological examinations of 22 patients with PA. Results The baseline plasma aldosterone concentration (PAC) of most aldosterone-producing adenomas (APAs) was over 250 pg·ml -1 . In the diagnosis of APA, the senstivity of CT was 75% and the specificity of CT was 100%; the senstivity and specificity of PST were 87% and 100%, respectively. The examination results of CT and PST had no statistical significant correlativity (P>0.05) and had bad consistency (P>0.05), and the diagnostic efficiency of them had no significant difference (P>0.05). Conclusions The baseline PAC and the result of PST suggest as the best diagnostic index and methods of APA. Both CT and PST have high value in the differential diagnosis. Both CT and PST cannot be substituted for each other.
出处 《湖南医科大学学报》 CSCD 北大核心 2001年第4期389-391,共3页 Bulletin of Hunan Medical University
关键词 醛固酮增多症 X光计算机断层造影术 体位刺激试验 诊断 hyperaldosteronism tomography, X-ray computed posture stimulation test * diagnosis
  • 相关文献

参考文献1

  • 1Young W F Jr,Endocrinol Metab Clin North Am,1988年,17卷,367页

同被引文献22

  • 1全国血压抽样调查协作组.中国各民族高血压患病情况调查[J].高血压杂志,1995,3(A01):24-30. 被引量:38
  • 2王志华,初少莉,陈绍行,杜俭,陆旭辉,钱文琪,吴顺娣,郭冀珍,朱鼎良.高血压住院患者病因及危险因素分析[J].高血压杂志,2005,13(8):504-509. 被引量:82
  • 3Masao Omura, Jun Saito, Kunio Yamaguchi,et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient chnic in Japan[J]. Hypertens Res,2004,27(3):193-202.
  • 4Conn JW. Primay aldosteronism:a new clinical syndrome [J]. J Lab Clin Med, 1955,45( 1 ):3-17.
  • 5Irong I. Primary A ldo steronism[ M ]. In: B iglieri EG. New York:Endocrine Hypertensio Raven Press L td, 1990:71- 83.
  • 6Ferriss JB. Primary Hyperaldosteronism:Conn's syndrome and similar disorders [ M ]. In: Robertson J IS, ed. Handbook of Hypertension. New York: Elsevier Science Publishers, Biomedical Division, 1992: 357-379.
  • 7Hiramatsu K,Yamada T,Yukimuta Y,et al. A screening test to identify aldostemne producing adenoma by measuring plasma rein activity. Results in hypertensive patients [J]. Arch Int Med,1981,141(12):1589-1593.
  • 8Lim OP, Dow E, Brennan G, et al. High prevalence of primary aldosteronism in the Tayside hypertension clinic population[J]. J Hum Hypertens,2000,14(3) :311-315.
  • 9Stowasser M. Hyperaldosteronism primary versus tertiary [J]. J Hypertens,2002,20(12) : 1769-1773.
  • 10Lim PO,Young WF,Maedonald TM. A review of the medical treatment of primary aldosteronism[J]. J Hypertens, 2001,19(3 ) : 253-361.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部